Consensus EPS · Q4 2025
$0.78
Consensus revenue · Q4 2025
$5.3B
Analysts
18
Last reported
Feb 4, 2026
Analyst consensus
Based on estimates from 18 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $5.2B | $5.3B | $5.3B |
| EPS | $0.77 | $0.78 | $0.81 |
| EBITDA | $1.2B | $1.2B | $1.2B |
| EBIT | $789.3M | $792.3M | $795.3M |
| Net income | $1.2B | $1.2B | $1.2B |
- Revenue$5.3B
- EPS$0.78
- EBITDA$1.2B
- EBIT$792.3M
- Net income$1.2B
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.3B | $5.3B | +0.2% | $0.80 | $0.78 | +2.5% |
- Q4 2025+0.2%+2.5%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
No community consensus
No TickerLeague members predicted Boston Scientific (BSX) Q4 2025 before it reported.
Analyst price target
Based on price targets from 6 analysts.
- Low
- $55.00
- Consensus
- $78.00
- Median
- $70.00
- High
- $120.00
- Current
- $42.97
- Upside
- +81.5%
Upside calculated vs most recent trading price of $42.97.
Analyst ratings
Consensus: Buy — based on 44 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 16, 2026 | Truist Securities | maintain | Buy | Buy |
| Jul 15, 2026 | Mizuho | maintain | Outperform | Outperform |
| Jul 13, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jul 8, 2026 | Needham | maintain | Buy | Buy |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Jun 25, 2026 | Stifel | maintain | Buy | Buy |
| Jun 24, 2026 | Jefferies | maintain | Buy | Buy |
| Jun 16, 2026 | BTIG | maintain | Buy | Buy |
| Jun 4, 2026 | Truist Securities | maintain | Buy | Buy |
| Jun 3, 2026 | BTIG | maintain | Buy | Buy |
- Jul 16, 2026Truist SecuritiesBuy
- Jul 15, 2026MizuhoOutperform
- Jul 13, 2026RBC CapitalOutperform
- Jul 8, 2026NeedhamBuy
- Jul 6, 2026Evercore ISI GroupOutperform
- Jun 25, 2026StifelBuy
- Jun 24, 2026JefferiesBuy
- Jun 16, 2026BTIGBuy
- Jun 4, 2026Truist SecuritiesBuy
- Jun 3, 2026BTIGBuy
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.